Torus Ventures v. HealthMarkets Insurance Agency: Voluntary Dismissal in 42 Days
Torus Ventures, LLC filed a patent infringement action in the Northern District of Texas against HealthMarkets Insurance Agency Inc, asserting US7203844B1—a patent covering a recursive security protocol for digital copyright control. The case ended in voluntary dismissal without prejudice just 42 days after filing, before HealthMarkets filed any responsive pleading.
Pre-answer dismissal raises re-filing risk for HealthMarkets
On May 21, 2025, Torus Ventures, LLC filed suit against HealthMarkets Insurance Agency Inc in the Northern District of Texas (Case No. 3:25-cv-01277), before Judge Brantley Starr. The sole patent asserted was US7203844B1 (App. No. US10/465274), which covers a method and system for a recursive security protocol for digital copyright control—a technology relevant to platforms managing licensed digital content and access credentials.
On July 2, 2025, just 42 days after filing, Torus Ventures invoked Federal Rule of Civil Procedure 41(a)(1)(A)(i) to voluntarily dismiss the action without prejudice. That procedural vehicle is available as of right when the defendant has not yet served an answer or a motion for summary judgment, which was the case here. A dismissal without prejudice does not resolve the underlying merits and leaves Torus Ventures free to refile the same claims, subject to applicable statutes of limitations.
The speed of resolution—42 days from filing to dismissal—is notably short even for pre-answer exits, and the public record does not disclose whether any settlement, licensing negotiation, or other agreement accompanied the dismissal. The absence of a responsive pleading from HealthMarkets means no claim construction, invalidity contentions, or fee-shifting analysis entered the record. Whether this dismissal reflects a resolved commercial dispute or a strategic pause in enforcement remains unknown from available public filings.
Filing to Voluntary dismissal in 42 days
42 days — resolved before defendant answered; well below median N.D. Texas patent case duration
Voluntarily dismissed: what the Rule 41 exit means for both parties
Rule 41(a)(1)(A)(i): dismissal as of right, no court approval needed
Federal Rule of Civil Procedure 41(a)(1)(A)(i) permits a plaintiff to dismiss an action without a court order at any time before the defendant serves an answer or a motion for summary judgment. HealthMarkets had not yet done either, so Torus Ventures could exit unilaterally. The dismissal is self-executing upon filing of the notice—no judicial sign-off is required.
Pre-answer voluntary dismissalPublic record is silent on whether a settlement was reached
The notice expressly states ‘without prejudice,’ meaning Torus Ventures retains the right to refile the same infringement claims against HealthMarkets. Dismissals without prejudice carry no res judicata effect. However, the public record does not disclose whether any side agreement—such as a license, covenant not to sue, or monetary settlement—accompanied the dismissal. Absent such an agreement, HealthMarkets remains exposed to a future refiling.
Refiling risk remains openNo judgment, no fee award — but no immunity either
HealthMarkets secured dismissal of the immediate action without incurring the expense of full merits litigation, and no adverse judgment was entered. However, because the dismissal is without prejudice, HealthMarkets cannot claim the matter is fully resolved unless a private agreement exists. The defendant assembled a four-attorney team from Figari & Davenport and Robins Kaplan, suggesting the matter was taken seriously despite its short duration.
No prevailing party determinationDigital copyright control patents: enforcement window stays open
US7203844B1 covers recursive security protocols for digital copyright control—technology with potential relevance to insurance portals and digital content delivery platforms. The without-prejudice exit preserves Torus Ventures’ enforcement posture. Companies in sectors using licensed digital infrastructure should note that pre-answer dismissals by patent assertion entities often precede refiling or parallel licensing campaigns rather than signalling abandonment of the patent.
PAE enforcement patternFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Torus Ventures, LLC | Company | Patent assertion entity — holder of US7203844B1, digital copyright control technologySearch in Eureka ↗ |
| Defendant | HealthMarkets Insurance Agency Inc | Company | HealthMarkets Insurance Agency Inc — insurance distribution and agency services companySearch in Eureka ↗ |
| Plaintiff counsel | Isaac Philip Rabicoff | Attorney | Counsel for Torus Ventures, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Rabicoff Law LLC | Law Firm | Representing Torus Ventures, LLCSearch in Eureka ↗ |
| Defendant counsel | Andrew G Jubinsky | Attorney | Counsel for HealthMarkets Insurance Agency IncSearch in Eureka ↗ |
| Defendant counsel | Cameron Elliot Jean | Attorney | Counsel for HealthMarkets Insurance Agency IncSearch in Eureka ↗ |
| Defendant counsel | Matt Woods | Attorney | Counsel for HealthMarkets Insurance Agency IncSearch in Eureka ↗ |
| Defendant counsel | Nicole Olson | Attorney | Counsel for HealthMarkets Insurance Agency IncSearch in Eureka ↗ |
| Defendant law firm | Figari & Davenport LLP | Law Firm | Representing HealthMarkets Insurance Agency IncSearch in Eureka ↗ |
| Defendant law firm | Figari Davenport LLP | Law Firm | Representing HealthMarkets Insurance Agency IncSearch in Eureka ↗ |
| Defendant law firm | Robins Kaplan, LLP | Law Firm | Representing HealthMarkets Insurance Agency IncSearch in Eureka ↗ |
| Defendant law firm | Robins, Kaplan, Miller & Ciresi LLP | Law Firm | Representing HealthMarkets Insurance Agency IncSearch in Eureka ↗ |
| Presiding judge | Judge Brantley Starr | Judge | Texas Northern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The dismissal notice invokes Rule 41(a)(1)(A)(i) and explicitly states ‘without prejudice,’ meaning no merits determination was made and no preclusive effect attaches. The notation that HealthMarkets had not yet answered is legally significant: it confirms the procedural right to dismiss without consent and forecloses any argument that a court order was required. The absence of a cost or fee provision in the notice is consistent with pre-answer exits, where fee-shifting under 35 U.S.C. § 285 is rarely pursued.
US7203844B1 — Recursive security protocol for digital copyright control
US7203844B1 (Application No. US10/465274) claims a method and system for a recursive security protocol designed for digital copyright control. The patent addresses layered access control and content protection mechanisms in digital distribution environments. Its recursive architecture suggests protection that applies iteratively across multiple system levels—potentially covering credential verification, licence enforcement, and content delivery pipelines. The application date context places this invention in an era when DRM and digital content distribution were rapidly expanding.
From a competitive standpoint, the patent’s breadth in covering recursive security protocols makes it potentially relevant to any platform that manages tiered access to licensed digital content—including insurance portals, SaaS licensing systems, and digital media delivery networks. The assertion against an insurance agency suggests the patentee views web-based credentialing and access management flows as within scope. Companies building or operating such systems should assess claim exposure before this patent is re-asserted.
Should you run an FTO analysis against US7203844B1?
Any organisation operating digital content delivery, licence management, or access-credentialing systems should consider a freedom-to-operate review against US7203844B1. The patent’s assertion against an insurance agency—a sector not traditionally associated with DRM—suggests the patentee interprets its claims broadly. R&D and product teams building recursive or layered security protocols for digital asset access are particularly exposed, especially in N.D. Texas, a jurisdiction known for fast-moving patent dockets.
PatSnap Eureka’s FTO Search Agent can map the independent claims of US7203844B1 against your product architecture, flag prior art that may support invalidity arguments, and surface any continuation or related applications that could extend the patent family’s reach. Given the without-prejudice dismissal, a proactive FTO analysis now is more cost-effective than reactive litigation preparation after a refiling.
Run a freedom-to-operate analysis on US7203844B1 to assess your product’s exposure
Run FTO in Eureka →Similar digital copyright control patent cases in N.D. Texas
Explore related patent infringement actions asserting digital copyright control and security protocol patents before the Northern District of Texas.
What this case signals for the digital copyright control IP landscape
A 42-day pre-answer exit in N.D. Texas is a recognised PAE tactic — but the without-prejudice tag means the risk is not extinguished.
Pre-answer PAE dismissals often precede licensing campaigns, not retreats
When a patent assertion entity voluntarily dismisses before the defendant answers, it frequently signals a licensing resolution or a strategic repositioning rather than abandonment. US7203844B1 remains active as an enforcement asset. Companies operating digital content access or credentialing systems should monitor for re-assertion.
N.D. Texas / Judge Starr: a venue that rewards early procedural preparation
The Northern District of Texas under Judge Brantley Starr moves at pace. HealthMarkets’ deployment of four attorneys across two firms within 42 days reflects the court’s demanding scheduling norms. Any defendant served in this venue should mobilise invalidity and claim construction analysis immediately on receipt of a complaint.
Torus v HealthMarkets — key questions answered
The dismissal without prejudice means no merits ruling was made and Torus Ventures retains the right to refile its infringement claims based on US7203844B1 against HealthMarkets. No judgment was entered, no fee award was made, and the patent remains enforceable. HealthMarkets has no preclusive protection unless a private side agreement exists.
US7203844B1 covers a method and system for a recursive security protocol for digital copyright control. The assertion against HealthMarkets Insurance Agency suggests the patentee views web-based or portal-based access control and credentialing systems as potentially within the patent’s scope, reflecting a broad interpretation of ‘digital copyright control’ beyond traditional media DRM contexts.
Yes. A Rule 41(a)(1)(A)(i) dismissal without prejudice carries no preclusive effect and permits the plaintiff to refile, subject to applicable statutes of limitations. However, a second voluntary dismissal of the same claims would operate as a dismissal with prejudice under the ‘two-dismissal rule’ of Rule 41(a)(1)(B).
HealthMarkets engaged attorneys from both Figari & Davenport LLP and Robins Kaplan LLP. This level of resourcing for a short-duration case is consistent with N.D. Texas practice, where scheduling orders move quickly, and suggests the defendant took the infringement allegations seriously enough to prepare a substantive defence even before the case resolved.
Judge Brantley Starr in the Northern District of Texas is known for active case management and demanding scheduling norms. Cases before Judge Starr typically proceed on tight timelines, which may have influenced the pace of pre-dismissal activity. His court is a recognised venue for patent assertion entity filings targeting Texas-based companies.
PatSnap Eureka searches patents and litigation data to answer instantly.